CeriBell, Inc. (CBLL)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Diagnostic Kits / Equipment	89.06M	65.44M	45.23M	25.92M
Diagnostic Kits / Equipment Growth	36.09%	44.71%	74.47%	-
Total	89.06M	65.44M	45.23M	25.92M
Total Growth	36.09%	44.71%	74.47%	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
United States	89.06M	65.44M	45.23M	25.92M
United States Growth	36.09%	44.71%	74.47%	-
Total	89.06M	65.44M	45.23M	25.92M
Total Growth	36.09%	44.71%	74.47%	-

Data Source: S&P Global Market Intelligence Last updated: May 11, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error